Likhitweerawong, Narueporn
Montanaro, Federica Alice Maria
Santos, Ellery R.
Wang, Jun Yi
Dejputtawat, Waralee
Narasimhan, Udayakumar
Klusek, Jessica
Maltman, Nell
Schneider, Andrea
Tassone, Flora
Hagerman, Randi J.
Article History
Received: 17 July 2025
Accepted: 27 October 2025
First Online: 26 November 2025
Declarations
:
: R.J.H. has received funding from Zynerba Pharmaceuticals and Tetra/Shionogi for clinical trials in those with fragile X syndrome. The sponsors had no role in the design, execution, interpretation, or writing of the study. The other authors declare no conflicts of interest.